Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
about
Multiple molecular targets of resveratrol: Anti-carcinogenic mechanismsCombined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladderEnhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.Matrix metalloproteinases in Vietnamese patients with colorectal cancerDetection of gelatinase B activity in serum of gastric cancer patients.Inhibition of tumor growth and metastasis by non-small cell lung cancer cells transfected with cyclin D1-targeted siRNAMatrix metalloproteinase-9 in lung remodeling.Expression and correlation of CD44v6, vascular endothelial growth factor, matrix metalloproteinase-2, and matrix metalloproteinase-9 in Krukenberg tumorPerfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression.Detection of type IV collagenase activity in malignant ascitesActive MMP-2 effectively identifies the presence of colorectal cancer.The role of inflammation and proteinases in tumor progression.Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura.Transforming growth factor-beta1 modulates metalloproteinase-2 and -9, nitric oxide, RhoA and alpha-smooth muscle actin expression in colon adenocarcinoma cells.In situ zymography and immunolabeling in fixed and decalcified craniofacial tissues.Minocycline reduces renal microvascular leakage in a rat model of ischemic renal injury.Downregulation of monocytic differentiation via modulation of CD147 by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases.Improving the stability of chitosan-gelatin-based hydrogels for cell delivery using transglutaminase and controlled release of doxycycline.Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system.Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon Cancer.
P2860
Q24648759-8E6B8FDD-52BE-4348-AE9F-4B8DA43D599EQ33253538-291D2403-915B-4834-876B-B21B82616D36Q33564917-15889C2C-9991-4445-B386-38004BBB9E6BQ33598343-9090B80E-B694-4D39-A50A-B41C1D81377FQ33829871-41714EBD-7760-47C8-A714-E8B6DCC7B4A7Q34167898-46DCD96D-4887-4FED-B5A1-DE9ECAADB27BQ35032152-5D7BD869-72C6-4415-9735-AB4791A0EC5AQ35064517-CF997725-34A4-4B71-A19D-A75B4E4B3038Q36261424-1F415120-D67D-4379-86A6-2CAA02DFF5DFQ36308918-43E17FB3-D041-4961-920F-1E43DD47F391Q37415978-2572D830-96E9-4ECF-8243-1B4837686DA8Q38020728-665AC322-B5CC-4DBB-B7F2-CACBD710F618Q38107451-103F5330-954D-4098-9090-69273F919671Q38308730-4B420BF3-4182-447D-A7E7-A70F57D963B8Q39769386-953FEA4F-F6B2-45B6-928C-3ACDED5C17C8Q41316374-0CD77A00-E09A-4165-8060-642CB824C8CFQ45048780-8244B31C-A5BF-48F6-AB7A-54CDA19BE299Q47280518-A54A5F9F-009C-443F-94F4-1FF24ED5681DQ49594019-0609F2CB-B230-4793-B982-C135041B73C4Q50229564-E7631AA3-6521-4436-87C8-6B060EC0D36CQ51718754-531AE114-1E69-4D88-A283-C42C0417B138Q52980831-36A2B3CD-9E8D-4D19-91D7-71772E56A705Q55025617-E1164400-BD94-4279-97E7-FAA919621E97
P2860
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@ast
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@en
type
label
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@ast
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@en
prefLabel
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@ast
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.
@en
P2093
P2860
P356
P1476
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600366
P407
P577
2002-06-01T00:00:00Z